RxDoctor Payments Data

Tina Powell

Adult Health · Ridley Park, PANPI 1770509028

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,662 of the $7,541 with a category attached, or 88.4%. It is spread thinly across 54 manufacturers, the largest accounting for just 11.0% — the pattern of someone who eats at a lot of different presentations. Among adult health clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$7,541in general payments, 2019–2025

Across 291 payments — averaging $25.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$826
  • Daiichi Sankyo Inc.$769
  • Johnson & Johnson$736
  • E.r. Squibb & Sons, L.L.C.$603
  • Novartis$566
  • AbbVie$326
  • plus $4K from 48 others

What the payments were for

  • Consulting fees$4055%
  • Food & beverage$6,66288%
  • Education$4736%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,541 in reported general payments places this provider in the 90th percentile of 899 adult health providers in Pennsylvania.

See all adult health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$3,439
Medicare patients
21
Services billed
88

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban29$18,959
EliquisApixaban14$7,959
Fentanyl11$825
Hydroxyurea19$648
Oxycodone Hcl46$609
Acyclovir21$400
Ondansetron Hcl67$308
Anastrozole23$207
Prochlorperazine Maleate20$190
Letrozole14$146
Prednisone22$108
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine19$102
Tramadol Hcl14$36
Allopurinol12$28

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$736$18,95929 claims
PfizerEliquis$215$7,95914 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 899 adult health providers in Pennsylvania.

Other adult health in Ridley Park

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →